For families in remote villages across northeastern India, seeing a doctor often means long journeys over difficult terrain, lost daily wages, and sometimes, lifesaving treatment that comes too late.
New research, conducted by Essity for its global leading Tork professional hygiene brand, has uncovered the desire among staff in Long Term Care facilities for improved training in areas such as hand hygiene and cleaning procedures.
Alkermes respects the culture, customs and values of the people in the communities in which we operate. We seek to support and positively impact these communities through our grant programs, sponsorship contributions and volunteer support.
Made possible through funding support from Q4HE, Puerto Rico’s first post-COVID-19 Care Clinic was opened by SIM, and a growing number of patients experiencing long COVID symptoms have been receiving critical tailored care.
Now, forty years after the first monoclonal antibody therapy emerged, new indications and therapy types such as antibody drug conjugates (ADCs), bispecific antibodies, and multispecific antibodies are revolutionizing treatment options.
Bristol Myers Squibb has a long-standing partnership with The Leukemia & Lymphoma Society (LLS) and has been the top biopharma fundraising team for Light The Night® for more than a decade.
Illumina announced a new research test for genitourinary pathogen and antimicrobial resistance (AMR) identification. The Illumina Urinary Pathogen Infectious Disease/Antimicrobial Resistance (ID/AMR) Panel (UPIP) applies precision metagenomics to detect and quantify pathogens.
San Francisco Bay Area residents Jainu and Shruti Jogani had their newborn daughter, Reyna, at home for nearly three weeks when they noticed her exhibiting seizure-like symptoms—episodes so quick they weren’t able to capture them on video.
Better Together: Action for Healthy Kids and RMC Health join forces to tackle child health & well-being with greater impact. Together, the organizations will provide a wide range of resources to schools to meet the urgent needs of America’s youth and families.
We have developed and now manufacture and commercialize proprietary medicines for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder
Everyone’s financial journey is different. We make intentional efforts to meet the individual needs of clients and communities through a diverse range...
Highlighting the top news, commentary, and research for the week coming from SHQ. The highlights newsletter also spotlights one profiled organization...
